Iran's national package of essential noncommunicable disease interventions, launched in 2015 as the country's own adaptation of the World Health Organization's PEN framework for primary health care and first piloted in four districts. IraPEN is built around five clinical protocols: integrated screening and management of diabetes, hypertension and dyslipidemia aimed at preventing myocardial infarction and stroke; screening for breast and cervical cancer; screening for colorectal cancer; and screening for asthma and other respiratory disorders including chronic obstructive pulmonary disease. In its pilot districts the program screened more than 160,000 eligible people at baseline, and a follow-up evaluation of roughly 25,700 of them found measurable, if modest, reductions in ten-year cardiovascular risk scores for both men and women, leading researchers to conclude the program had achieved a real but limited effect that further modification could improve.
Facts
Program StatusPiloted; MoHME began with a four-district pilot to assess feasibility and cost before considering full-scale implementation 1 Sponsoring BodyMinistry of Health and Medical Education (MoHME), Iran, and the country's universities of medical sciences 1 Health GoalScreening and referral for the most common noncommunicable diseases (cardiovascular disease and stroke, breast, cervical and colorectal cancer, respiratory disease) at primary health care centers 1 Geographic ScopeIran, piloted in four districts across four provinces before any wider scale-up 1 Classification
Program Kind Sources
1. PLOS Global Public Health: The Incremental Cost of Implementing IraPEN in Iran (2023)
PLOS Global Public Health, via PubMed CentralIntroduction, paragraph 3
This program was funded by MoHME and universities of medical sciences responsible for delivering healthcare programs at the district level.
Introduction, paragraph 2
IraPEN is an attempt by healthcare policymakers and deputies to address challenges regarding NCD prevention and control in Iran by implementing a screening and referral system for the most common NCDs or with highest burden by healthcare providers at primary health care centers
Abstract
IraPEN was piloted in four districts of Iran.
Introduction, paragraph 3 (pilot timeframe sentence)
we seek address the knowledge gap regarding the cost and resource use of IraPEN in the two pilot districts of Naqadeh and Shahreza from February 2016 to March 2017
Introduction, paragraph 3 (piloting rationale sentence)
MoHME started with piloting IraPEN in 4 districts to assess the feasibility and incremental cost of the program.
Introduction, paragraph 2 (name derivation sentence)
IraPEN (the PEN package implemented in Iran) is the name of the plan adopted from both WHO PEN package and National Action Plans for NCDs
Program classification, entity description sentence
IraPEN is built around five clinical protocols: integrated screening and management of diabetes, hypertension and dyslipidemia aimed at preventing myocardial infarction and stroke; screening for breast and cervical cancer; screening for colorectal cancer; and screening for asthma and other respiratory disorders including chronic obstructive pulmonary disease.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.